ES516840A0 - Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina. - Google Patents
Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina.Info
- Publication number
- ES516840A0 ES516840A0 ES516840A ES516840A ES516840A0 ES 516840 A0 ES516840 A0 ES 516840A0 ES 516840 A ES516840 A ES 516840A ES 516840 A ES516840 A ES 516840A ES 516840 A0 ES516840 A0 ES 516840A0
- Authority
- ES
- Spain
- Prior art keywords
- cyclodextrin
- procedure
- water
- poorly soluble
- inclusion complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU813147A HU190356B (en) | 1981-10-27 | 1981-10-27 | Process for preparing steroid-gamma-cyclodextrin inclusion complexes with high water-solubility |
Publications (2)
Publication Number | Publication Date |
---|---|
ES516840A0 true ES516840A0 (es) | 1983-09-16 |
ES8308571A1 ES8308571A1 (es) | 1983-09-16 |
Family
ID=10962794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES516840A Expired ES8308571A1 (es) | 1981-10-27 | 1982-10-26 | Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina. |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5883699A (es) |
BE (1) | BE894825A (es) |
DD (1) | DD208549A5 (es) |
DE (1) | DE3238800A1 (es) |
DK (1) | DK474782A (es) |
ES (1) | ES8308571A1 (es) |
FR (1) | FR2515187A1 (es) |
GB (1) | GB2109381A (es) |
HU (1) | HU190356B (es) |
IT (1) | IT1191049B (es) |
NL (1) | NL8204122A (es) |
SE (1) | SE8206055L (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196230B (en) * | 1983-12-29 | 1988-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect |
GB2162529B (en) * | 1984-06-08 | 1988-03-02 | Nitrokemia Ipartelepek | B-cyclodextrin complex of benzene sulphonyl urea derivatives |
US5223295A (en) * | 1988-01-22 | 1993-06-29 | Asterol International | Process for the elimination of steroid compounds contained in substance of biological origin |
EP0381747A4 (en) * | 1988-08-15 | 1991-09-11 | American Maize-Products Company | Water soluble branched beta cyclodextrin steroid complex |
US5229370A (en) * | 1988-08-15 | 1993-07-20 | Ammeraal Robert N | Water soluble branched beta cyclodextrin steroid complex |
CA2087452A1 (en) * | 1991-05-20 | 1992-11-21 | Toshiro Tsuda | Steriod compound combined with polysaccharide |
US20040152664A1 (en) * | 1998-09-02 | 2004-08-05 | Allergan, Inc. | Prednisolone compositions |
DE60122764T2 (de) * | 2000-11-02 | 2007-10-11 | N.V. Organon | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen |
EP1216712A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Cyclodextrin-drospirenone inclusion complexes |
EP1216713A1 (en) | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
EP1353699B1 (en) * | 2000-12-20 | 2012-02-01 | Bayer Pharma Aktiengesellschaft | Beta-cyclodextrin-drospirenone inclusion complexes |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
EP2825567A2 (en) * | 2012-03-13 | 2015-01-21 | Amphidex A/S | Production of stabilized channel type cyclodextrin crystals |
-
1981
- 1981-10-27 HU HU813147A patent/HU190356B/hu not_active IP Right Cessation
-
1982
- 1982-10-20 DE DE19823238800 patent/DE3238800A1/de not_active Withdrawn
- 1982-10-25 SE SE8206055A patent/SE8206055L/xx not_active Application Discontinuation
- 1982-10-26 IT IT23942/82A patent/IT1191049B/it active
- 1982-10-26 GB GB08230513A patent/GB2109381A/en not_active Withdrawn
- 1982-10-26 DD DD82244272A patent/DD208549A5/de unknown
- 1982-10-26 ES ES516840A patent/ES8308571A1/es not_active Expired
- 1982-10-26 NL NL8204122A patent/NL8204122A/nl not_active Application Discontinuation
- 1982-10-26 DK DK474782A patent/DK474782A/da not_active Application Discontinuation
- 1982-10-26 FR FR8217943A patent/FR2515187A1/fr not_active Withdrawn
- 1982-10-27 BE BE0/209341A patent/BE894825A/fr not_active IP Right Cessation
- 1982-10-27 JP JP57187658A patent/JPS5883699A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IT8223942A0 (it) | 1982-10-26 |
BE894825A (fr) | 1983-02-14 |
NL8204122A (nl) | 1983-05-16 |
DE3238800A1 (de) | 1983-05-05 |
DK474782A (da) | 1983-04-28 |
SE8206055L (sv) | 1983-04-28 |
GB2109381A (en) | 1983-06-02 |
SE8206055D0 (sv) | 1982-10-25 |
IT1191049B (it) | 1988-02-24 |
ES8308571A1 (es) | 1983-09-16 |
FR2515187A1 (fr) | 1983-04-29 |
HU190356B (en) | 1986-08-28 |
DD208549A5 (de) | 1984-04-04 |
JPS5883699A (ja) | 1983-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES517764A0 (es) | Procedimiento de preparacion de nuevos derivados esteroides sustituidos en 11b. | |
JPS5570308A (en) | Water antifrothing agent* its preparation and its use | |
SE7811853L (sv) | Isertagbar rullstol | |
IT1154356B (it) | Complesso di catetere | |
NL7704035A (nl) | Verbetering van de werkwijzen ter bereiding van door fotopolymerisatie in water oplosbare acryl- polymeren. | |
DK158391C (da) | Afloebsanlaeg | |
BR8200424A (pt) | Cateter para diagnostico para fazer cistometrograma | |
ES516840A0 (es) | Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina. | |
NL7903775A (nl) | Werkwijze ter bereiding van in water onoplosbaar carboxymethylcellulose. | |
MX4350E (es) | Procedimiento para la preparacion de compuestos monoazoicos insolubles en agua | |
BR7802684A (pt) | Poliester termofixavel soluvel em agua | |
GB2035114B (en) | Filtering used water soluble cutting agents | |
NL7900264A (nl) | 4-pyridon-3-carbonzuurderivaten alsmede de bereiding ervan. | |
MX162869B (es) | Procedimiento para la preparacion de complejos de anfotero-acido graso | |
MX144552A (es) | Procedimiento para la preparacion de colorantes monoazo solubles en agua | |
ES511058A0 (es) | Procedimiento para preparar nuevos derivados de fenoxibencilo. | |
MX155941A (es) | Procedimiento para preparar colorantes disazoicos solubles en agua | |
DD135016A1 (de) | Streifenleitungsrichtungskoppler geringer koppeldaempfung | |
DK172879A (da) | Urinekstraktionssystem | |
NL7901542A (nl) | Werkwijze ter bereiding van pek. | |
IT1163673B (it) | Sistema di ancoraggio | |
MX160240A (es) | Procedimiento para recuperar molibdeno disuelto | |
IT8247833A0 (it) | Derivato di colesterolo idrosolubile dotato di attivita' farmacologica e procedimento di preparazione | |
GB2025394B (en) | Benzoylphenoxyalkanoic acid derivatives their use and preparation | |
MY8500351A (en) | Pyridine derivatives as anti-inflammatory and immuno-regulatory agents |